Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01852617
Other study ID # 1U48DP001948-01
Secondary ID
Status Completed
Phase N/A
First received June 22, 2011
Last updated January 29, 2015
Start date October 2011
Est. completion date August 2014

Study information

Verified date January 2015
Source Institute for Clinical Effectiveness and Health Policy
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardUnited States: Centers for Disease Control and PreventionArgentina: Institutional Review BoardArgentina: Institute for Clinical Effectiveness and Health PolicyUruguay: Comite de Etica
Study type Interventional

Clinical Trial Summary

Argentina and Uruguay are among the countries with the highest proportion of pregnant women who smoke. The implementation of an effective smoking cessation intervention would have a significant impact on the health of mothers and children. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide. However, it is under used in Argentina and Uruguay. We will conduct a two-arm, parallel cluster randomized controlled trial of an implementation intervention in 20 prenatal clinics in Argentina and Uruguay. Our primary hypothesis is that the intervention is feasible in prenatal clinics in Argentina and Uruguay and will increase the frequency of women receiving tobacco use cessation counseling during pregnancy. Our secondary hypothesis is that the intervention will decrease the frequency of women who smoke by the end of their pregnancies. Prenatal clinics will be randomly allocated to either an intervention or a control group after a baseline data collection period. Midwife facilitators in the ten intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The ten clinics in the control group will continue with their standard in-service activities. A follow-up data collection will be conducted immediately after delivery. The intervention will be tailored by formative research to be readily applicable to local prenatal care services at busy maternity hospitals, as well as to be acceptable to local pregnant women and health providers. The study will be conducted in 48 months.


Recruitment information / eligibility

Status Completed
Enrollment 6858
Est. completion date August 2014
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender Female
Age group 12 Years to 49 Years
Eligibility Inclusion Criteria por prenatal clinics:

- Not having a smoking cessation program based on the "5 A's" for pregnant women in place.

- An estimated frequency of women receiving the "5 A's" intervention below 20%

- Having midwives or nurse-midwives as part of the hospital or primary health center staff.

- Having signed a letter of intention to participate in the project.

- Having at least 400 new pregnant women per year.

Exclusion Criteria for prenatal clinics:

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Behavioral:
Training in smoking cessation counseling
Midwife facilitators in the intervention clinics will be identified and trained to deliver the "5 A's" to pregnant women and will then disseminate and implement the program. The "5 A's" (Ask, Advise, Assess, Assist, Arrange) is a strategy consisting of a brief cessation counseling session of 5-15 minutes delivered by a trained provider, which is considered the standard of care worldwide

Locations

Country Name City State
Argentina Hospital Lucio Meléndez Adrogué Buenos Aires
Argentina Hospital Evita Pueblo Berazategui Buenos Aires
Argentina Hospital M.V de Martínez General Pacheco Buenos Aires
Argentina Hospital San Roque Gonnet La Plata
Argentina Hospital Narciso López Lanús Buenos Aires
Argentina Hospital Héroes de Malvinas Merlo Buenos Aires
Argentina Hospital Municipal Ostaciana B. de Lavignolle Morón Buenos Aires
Argentina Hospital Materno Infantil de San Isidro San Isidro Buenos Aires
Argentina Hospital Bocalandro Tres de Febrero Buenos Aires Province
Argentina Hospital Maternidad Santa Rosa Vicente López Buenos Aires
Uruguay Centro de Salud Badano Repetto Montevideo
Uruguay Centro de Salud Cerro Montevideo
Uruguay Centro de Salud Misurraco Montevideo
Uruguay Centro de Salud Saint Bois Montevideo
Uruguay Centro Materno Infantil 1 Montevideo
Uruguay Centro Materno Infantil 2 Montevideo
Uruguay Centro Materno Infantil 3 Montevideo
Uruguay Centro Materno Infantil 4 Montevideo
Uruguay Centro Materno Infantil 5 Montevideo
Uruguay Centro Materno Infantil 6 Montevideo
Uruguay Hospital Canzani Montevideo
Uruguay Hospital Pereira Rossell Montevideo

Sponsors (3)

Lead Sponsor Collaborator
Institute for Clinical Effectiveness and Health Policy Centers for Disease Control and Prevention, Tulane University

Countries where clinical trial is conducted

Argentina,  Uruguay, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency of women receiving the cessation smoking advice Frequency of women receiving the "5 A's" (ask smoking status of all women; advise smokers to quit; assess their willingness to make a quit attempt; assist their attempt by providing skills and materials for tobacco cessation; arrange: monitor smoking status at all prenatal visits) in women having prenatal care at the participating prenatal clinics. Interviews during the first 12 hours after delivery No
Secondary Frequency of women who smoke at the end of pregnancy Frequency of women who smoke at the end of pregnancy: Women will be interviewed during their postpartum hospital stay and saliva samples will be taken for cotinine analysis. Interviews and saliva samples during the first 12 hours after delivery No
Secondary Frequency of providers' positives attitudes and readiness to change Frequency of positives attitudes and readiness to provide counseling for smoking cessation to women following the "5 A's" model among midwives working at participating prenatal clinics. Assessed through a self-administered questionnaire. 6 months before and after the implementation of the intervention No
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Completed NCT02523755 - Evaluation of Regional Distribution of Ventilation During Labor With or Without Epidural Analgesia Phase 4